Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
Zhigang Cao, Li Xu, Shuli Zhao
Biochemical and Biophysical Research Communications (2019) Vol. 515, Iss. 2, pp. 345-351
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
María Isabel Mosquera Heredia, Luis Carlos Morales, Oscar M. Vidal, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 96
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance
Fabrizio Fontana, Emanuela Carollo, Genevieve E. Melling, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 749-749
Open Access | Times Cited: 65
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 59
Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
Madita Wandrey, Jadwiga Jabłońska, Roland H. Stauber, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2033-2033
Open Access | Times Cited: 25
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 15
Role of noncoding RNA in drug resistance of prostate cancer
Lifeng Ding, Ruyue Wang, Danyang Shen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 52
Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment
Qi Chen, Yuefeng Li, Yueqin Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 46
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
Rebecca Raue, Ann-Christin Frank, Shahzad N. Syed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2210-2210
Open Access | Times Cited: 43
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors
Chuanshi He, Linlin Wang, Ling Li, et al.
Translational Oncology (2021) Vol. 14, Iss. 12, pp. 101231-101231
Open Access | Times Cited: 31
Molecular mechanisms and clinical applications of exosomes in prostate cancer
Xiaolin Cui, Qiang Fu, Xueying Wang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p
Soo Hyun Kang, Su Young Oh, K. Y. Lee, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 460-479
Open Access | Times Cited: 12
The Role of Extracellular Vesicles in the Treatment of Prostate Cancer
Cong Hu, Qi Chen, Tianyang Wu, et al.
Small (2024)
Closed Access | Times Cited: 4
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance
Haodong Zhang, Bohan Wu, Y. N. Wang, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 498-498
Open Access
Small extracellular vesicles: crucial mediators for prostate cancer
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Small Extracellular Vesicles from Radioresistant H3K27M-Pediatric Diffuse Midline Glioma Cells Modulate Tumor Phenotypes and Radiation Response
Viral Oza, Kenan A. Flores, Yelena Chernyavskaya, et al.
(2025)
Open Access
Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells
Shifeng Shi, Xin Huang, Xiao Ma, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0225290-e0225290
Open Access | Times Cited: 32
Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant
Masafumi Tsuruda, Hirofumi Yoshino, Shunsuke Okamura, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232545-e0232545
Open Access | Times Cited: 29
miRNAs in prostate cancer: Intercellular and extracellular communications
Fumihiko Urabe, Yusuke Yamamoto, Takahiro Kimura
International Journal of Urology (2022) Vol. 29, Iss. 12, pp. 1429-1438
Open Access | Times Cited: 18
Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers
Jaya Aseervatham
Biology (2023) Vol. 12, Iss. 5, pp. 710-710
Open Access | Times Cited: 9
Extracellular vesicles and prostate cancer management: a narrative review
Fumihiko Urabe, Yuta Yamada, Shutaro Yamamoto, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 3, pp. 442-453
Open Access | Times Cited: 3
Current Landscape of Exosomal Non-coding RNAs in Prostate Cancer: Modulators and Biomarkers
Yongxing Li, Xiaoqi Tang, Binpan Wang, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1351-1362
Open Access | Times Cited: 3
Exosomes and prostate cancer management
Virginie Vlaeminck‐Guillem
Seminars in Cancer Biology (2021) Vol. 86, pp. 101-111
Open Access | Times Cited: 19
Extracellular vesicles for precision medicine in prostate cancer – Is it ready for clinical translation?
Harley Robinson, Matthew J. Roberts, Robert A. Gardiner, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 18-29
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top